| Identification | Back Directory | [Name]
HALOBETASOL | [CAS]
98651-66-2 | [Synonyms]
Halobetasol
Unii-9p6159hm7t
Ulobetasol [inn]
HALOBETASOL PROPIOTE
21-Chloro Diflorasone
Diflorasone 21-Chloro
Pregna-1,4-diene-3,20-dione, 21-chloro-6,9-difluoro-11,17-dihydroxy-16-methyl-, (6α,11β,16β)-
(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | [Molecular Formula]
C22H27ClF2O4 | [MDL Number]
MFCD00868926 | [MOL File]
98651-66-2.mol | [Molecular Weight]
428.9 |
| Chemical Properties | Back Directory | [Melting point ]
>218°C (dec.) | [storage temp. ]
Hygroscopic, -20°C Freezer, Under inert atmosphere | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [color ]
White to Pale Yellow | [Stability:]
Hygroscopic |
| Hazard Information | Back Directory | [Uses]
Halobetasol is a corticosteroid, an anti-inflammatory drug that is used to treat various dermatological conditions which mainly consist of various forms of psoriasis. | [Brand name]
Ultravate (Westwood-Squibb). | [in vivo]
| Animal Model: | New Zealand male albino rabbits[2] | | Dosage: | 0.5 ml | | Administration: | Intradermal injection | | Result: | Generated blisters were approximately 35% smaller. |
|
|
|